Join the patient advocates track at #ESMO24 ⬇️

Great effort by OncoAlert and Gil Morgan, MD 👏🏼💕

➡️ Tanja Spanic, Chair of ESMO PAWG and Europa Donna Board Member, kicked off the patient advocates reception at #ESMO24 in Barcelona Friday night ✨

#esmo24 Patient advocates session Understanding the cancer journey addressing advocacy role, doctor-patient communication, psychological aspects of uncertainty and how to cope with long term side effects. Ines Vaz Luis Natacha Bolaños OncoAlert ESMO - Eur. Oncology Luzia Travado

#ESMO24 another important but neglected topic for breast cancer survivors: Breastfeeding after hormone receptor-positive breast cancer and in BRCA carries #POSITIVEtrial Matteo Lambertini, MD PhD Fedro Peccatori MD, PhD BIG against Breast Cancer ESMO - Eur. Oncology OncoAlert

#esmo24 patient advocates session on Challenges in access to new oncology medicines with great speakers from #EMA, #OECD, Norwegian HTA body and World Health Organization (WHO). Natacha Bolaños ESMO - Eur. Oncology OncoAlert

No. If you want to judge symptoms, talk to patients. This is not just about brain metastases. Lab reports and imaging are important, but they will not tell you how patients feel. #ESMO24 #QoL #brainmetastases #patientvoice OncoAlert

NOW!! At #ESMO24 Tanja Spanic, #patientadvocate member of the BIG's Patient Partnership Initiative is presenting “Can #ArtificialIntelligence improve early detection of #cardiotoxicity after #BC treatment." HaDEA #EU4Health #bcsm #BIGagainstBC ESMO - Eur. Oncology

Peter Schmid presents the OS data from KN522 #ESMO24 publl now in NEJM. >6 year FU: 9% EFS benefit, 5% ⬆️OS with pembro pre/post op for TNBC. Pts with PCR had 95% survival +/-pembro but 6% ⬆️OS in nonPCR + pembro. Safety same. Huge advance for TNBC. Need biomarkers! OncoAlert

Excellent discussions by MarleenKokLab and Petros Grivas of 2 practice changing studies showing OS benefit from perioperative IO in TNBC and muscle invasive bladder cancer respectively at #ESMO2024 OncoAlert Many lessons on how to improve perioperative IO drug development!

The #OncoAlertTOPTweet 🚨DAY 3 #ESMO24 The Day 2 Round Up of #ESMO24

#ESMO24 Tanja Spanic, #patientadvocate member of the BIG's Patient Partnership Initiative will present today on “Adolescent and Young Adult Cancer: Important messages from patient’s perspectives” at 10:45 in the Pamplona Auditorium-Hall 3. HaDEA #EU4Health #bcsm ESMO - Eur. Oncology

#ESMO24! TREAT ctDNA trial, led by EORTC under BIG against Breast Cancer, compares elacestrant vs. standard ET in ER+/HER2- BC pts with #ctDNA relapse. Recruitment is ongoing and will reach 12 countries. Check 338 TiP poster presented by Michail ignatiadis HaDEA #EU4Health #bcsm ESMO - Eur. Oncology

Just presented at the #ESMO24 Presidential Symposium III by the king Andrea Botticelli a massive 🇮🇹 precision medicine effort….fantastic presentation my friend and super important data!!! #ESMOAmbassadors ESMO - Eur. Oncology OncoAlert #ItalianPride

#ESMO24 #patientadvocates session, Immunotherapy: New Indications, Hopes, and Perspectives: addressing toxicity and long-term impact, more research is needed on immunotherapy resistance, managing patient expectations is crucial, equal access to immunotherapy is essential ESMO - Eur. Oncology

I’m happy that we have more and more engaged people 💕

#ESMO24 in collaboration with SIOPE 🎗️ The greatest need for better outcome of Adolescent and Young Adult Cancer (AYA) with cancer; Delivering precision oncology, What clinicians need to successfully treat AYA and patient perspective 😊 Fedro Peccatori MD, PhD ESMO - Eur. Oncology OncoAlert

Strong evidence showing that getting a PhD is extremely bad for your mental health. A new paper uses Swedish medical records and matches them to the full population of PhD students for which the authors could get gender and birth year data from 2006 to 2017. After some exclusion